[1]
Wójcik , E., Kufel-Grabowska , J. and Gierba-Tomczyk , J. 2017. Efficacy and safety of non-pegylated liposomal doxorubicin in metastatic breast cancer therapy. OncoReview. 7, 4(28) (Dec. 2017), 162-167. DOI:https://doi.org/10.24292/01.OR.131217.